A globally diversified ETF portfolio with a strong focus on healthcare and dividend-paying stocks

Report created on Aug 3, 2025

Risk profile Info

4/7
Balanced
Less risk More risk

Diversification profile Info

4/5
Broadly Diversified
Less diversification More diversification

Positions

This portfolio predominantly comprises three ETFs, with a staggering 85.93% allocated to the Vanguard FTSE All-World UCITS ETF, signaling a strong preference for global diversification. The Xtrackers MSCI World Health Care UCITS ETF and the SPDR® S&P US Dividend Aristocrats UCITS ETF make up the remainder, focusing on the healthcare sector and dividend-paying companies, respectively. This composition suggests a balanced approach, leaning towards steady growth and income through dividends, with a broad geographic and sectoral spread.

Growth Info

Historically, this portfolio has shown a Compound Annual Growth Rate (CAGR) of 10.81%, with a notable maximum drawdown of -32.81%. Such performance metrics indicate the portfolio's ability to generate substantial growth over time, albeit with significant volatility. The days contributing to 90% of returns being concentrated in just 18.0 days highlight the impact of short-term market movements on performance, emphasizing the importance of long-term holding to capture full growth potential.

Projection Info

Monte Carlo simulations, which use historical data to forecast a range of possible outcomes, suggest a median projected growth of 176.8% over the analyzed period. With 945 out of 1,000 simulations showing positive returns, the portfolio demonstrates a high likelihood of future growth. However, the wide range between the 5th and 67th percentiles (-4.0% to 260.2%) underscores the uncertainty inherent in investing, highlighting the importance of risk tolerance in portfolio planning.

Asset classes Info

  • Stocks
    100%

The portfolio is entirely allocated to stocks, which is suitable for achieving long-term growth but comes with higher volatility compared to portfolios that include bonds or other asset classes. This single-asset-class approach simplifies the investment strategy but may not suit all risk tolerances, especially those of investors who prefer a buffer against stock market downturns through more conservative investments like bonds or cash.

Sectors Info

  • Technology
    22%
  • Health Care
    16%
  • Financials
    16%
  • Industrials
    10%
  • Consumer Discretionary
    10%
  • Telecommunications
    8%
  • Consumer Staples
    6%
  • Basic Materials
    3%
  • Energy
    3%
  • Utilities
    3%
  • Real Estate
    2%

Sector allocation shows a heavy emphasis on technology, healthcare, and financial services, each comprising a significant portion of the portfolio. This sectoral focus aligns with long-term growth trends, especially in technology and healthcare, but it also introduces sector-specific risks. The underrepresentation of traditionally defensive sectors like utilities and consumer defensive could mean higher volatility during market downturns.

Regions Info

  • North America
    67%
  • Europe Developed
    15%
  • Japan
    5%
  • Asia Emerging
    5%
  • Asia Developed
    3%
  • Australasia
    2%
  • Africa/Middle East
    1%
  • Latin America
    1%

Geographically, the portfolio is heavily weighted towards North America (67%), with smaller exposures to developed Europe and emerging markets in Asia. This distribution reflects a confidence in the stability and growth potential of North American markets, though it might limit exposure to potential high-growth opportunities in emerging markets. The modest allocation to Europe and Asia offers some diversification benefits but remains conservative.

Market capitalization Info

  • Mega-cap
    43%
  • Large-cap
    36%
  • Mid-cap
    19%
  • Small-cap
    2%

The portfolio's market capitalization breakdown—43% mega, 36% big, 19% medium, and a mere 2% small—indicates a bias towards larger, more established companies. This bias typically offers stability and lower volatility but might limit the portfolio's exposure to the rapid growth potential of smaller firms. The absence of micro-cap investments reinforces a conservative strategy focused on minimizing risk.

Risk vs. return

This chart shows the Efficient Frontier, calculated using your current assets with different allocation combinations. It highlights the best balance between risk and return based on historical data. "Efficient" portfolios maximize returns for a given risk or minimize risk for a given return. Portfolios below the curve are less efficient. This is informational and not a recommendation to buy or sell any assets.

Click on the colored dots to explore allocations.

The portfolio's current allocation suggests it is positioned near the Efficient Frontier, indicating an optimized risk-return profile based on historical data. However, it's important to remember that the Efficient Frontier is a theoretical concept that assumes historical returns and volatilities will persist, a limitation given market dynamics. Regular reviews and adjustments are essential to maintain this balance as market conditions evolve.

Ongoing product costs Info

  • SPDR® S&P US Dividend Aristocrats UCITS ETF EUR Dis 0.40%
  • Vanguard FTSE All-World UCITS ETF USD Accumulation 0.22%
  • Xtrackers MSCI World Health Care UCITS ETF 1C 0.25%
  • Weighted costs total (per year) 0.23%

With an overall portfolio cost (Total Expense Ratio, or TER) of 0.23%, the portfolio is efficiently managed in terms of expenses. Lower costs are crucial for long-term investment success, as they directly enhance net returns. The Vanguard FTSE All-World UCITS ETF, as the portfolio's cornerstone, boasts a particularly low cost, exemplifying cost-effective global diversification.

What next?

Create your own report?

Analyze your portfolio

Join our community!

Join Discord

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.

Help us improve Insightfolio

Your feedback makes a difference! Share your thoughts in our quick survey. Take the survey